Since the expression of PLCE1 and PRKCA was associated with clinicopathological characteristics, we then determined whether the expression of PLCE1 and PRKCA is linked to ESCC patient survival time. The gene discussed is PLCE1; the disease is esophageal squamous cell carcinoma.